Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity.
Lewis MA1, Hunihan L1, Watson J1, Gentles RG1, Hu S1, Huang Y1, Bronson J1, Macor JE1, Beno BR1, Ferrante M1, Hendricson A1, Knox RJ1, Molski TF1, Kong Y1, Cvijic ME1, Rockwell KL1, Weed MR1, Cacace AM1, Westphal RS1, Alt A1, Brown JM2.
The Journal of pharmacology and experimental therapeutics.J Pharmacol Exp Ther.2015 Sep;354(3):340-9. doi: 10.1124/jpet.115.224071. Epub 2015 Jun 24.
The present studies represent the first published report of a dopamine D1 positive allosteric modulator (PAM). D1 receptors have been proposed as a therapeutic target for the treatment of cognitive deficits associated with schizophrenia. However, the clinical utility of orthosteric agonist compounds
Journal of the American Chemical Society.J Am Chem Soc.2015 Aug 7. [Epub ahead of print]
A ten-step total synthesis of the polycyclic polyprenylated acylphloroglucinol (PPAP) natural product hyperforin is reported from 2-methylcyclopent-2-en-1-one. This route was enabled by a diketene annulation reaction and oxidative ring expansion strategy designed to complement the presumed biosynthe
Selected Paper : Computational Study of Cyclobutane-1,3-diylidene Dicarbenes : Ground-State Spin Multiplicity and New Strategy toward the Synthesis of Bicyclo[1.1.0]but-1(3)-enes
Bulletin of the Chemical Society of Japan 89(7), 770-778, 2016-07
Computational Study of Cyclobutane-1,3-diylidene Dicarbenes: Ground-State Spin Multiplicity and New Strategy Toward the Synthesis of Bicyclo[1.1.0]but-1(3)-enes
Bulletin of the Chemical Society of Japan advpub(0), 2016